Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67

Despite evidence of different malignant potentials, postoperative follow-up assessment is similar for G1 and G2 pancreatic neuroendocrine tumors (panNETs) and adjuvant treatment currently is not indicated. This study investigated the role of Ki67 with regard to recurrence and survival after curative resection of panNET.Patients with resected non-functioning panNET diagnosed between 1992 and 2016 from three institutions were retrospectively...